Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease
Prospective Multicenter Dynamic Cohort Study to Evaluate Phenotypic Profiles of Subjects With Chronic Obstructive Pulmonary Disease (COPD-BPCO 2 Study)
Initiatives Bronchopneumopathie Chronique Obstructive (BPCO)
500 participants
May 1, 2026
OBSERVATIONAL
Conditions
Summary
This prospective, multicenter, real-world observational cohort study will describe phenotypic profiles, patient characteristics, and treatments in adults with stable chronic obstructive pulmonary disease (COPD). The profiles observed in the current cohort will be compared with those of patients recruited between 2005 and 2018 in the previous COPD-BPCO 1 cohort. Patients will be followed for at least 3 years as part of routine care, with no study-specific visit or treatment.
Eligibility
Inclusion Criteria3
- Age 18 years or older.
- Stable COPD, defined as no exacerbation requiring treatment during the previous 4 weeks.
- Confirmed COPD diagnosis based on post-bronchodilator FEV1/FVC < 70%
Exclusion Criteria3
- Main diagnosis of bronchiectasis, asthma, or any other significant respiratory disease.
- Patients under legal protection.
- Pregnant women.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will be managed according to usual care at the investigator's discretion. The study does not assign any treatment, medicinal product, or medical device.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07627763